FIRE1, a Dublin-based medtech company, has raised $120 million in Series B funding led by Polaris Partners and Elevage Medical Technologies. The funding will support the rollout of Norm for clinical trials in the US, an implantable sensor placed inside the heart that provides remote monitoring of fluid volume.
- Company
- FIRE1 fire1foundry.com
- Round
- Series B
- Amount
- $120M
- Source
- irishtimes.com
- In the newsletter
- No. 135, Teardrop Vias & Grain Direction in Sheet Metal Bending